Orion Nutraceuticals Announces Name Change & Share Consolidation

(TheNewswire)

September 4, 2025 – TheNewswire- Vancouver, British Columbia, Orion Nutraceuticals Inc. (the “ Company ”) is pleasedto announce that, effective Tuesday, September 9, 2025, the Companywill be changing its name from Orion Nutraceuticals Inc. to PinetreeVentures Corp. (the “ NameChange ”) and completing a share consolidation(the “ Consolidation ”).

Under the Consolidation, all of the Company’s issuedand outstanding common shares (“ Shares ”) will beconsolidated on the basis of one (1) post-Consolidation Share for eachtwenty-five (25) pre-Consolidation Shares.

Following the Consolidation, the number of issued andoutstanding Shares will be reduced from 29,307,965 pre-ConsolidationShares to approximately 1,172,318 post-Consolidation Shares, eachwithout par value. The exercise and conversion prices of theCompany’s outstanding warrants and stock options, as well as thenumber of Shares issuable thereunder, will be proportionately adjustedin accordance with the terms of the Consolidation.

The new CUSIP number for the Shares will be 723328209and the new ISIN number will be CA7233282093.

No fractional Shares will be issued in connection withthe Consolidation. Any fractions of Shares will be rounded down to thenearest whole Share, and no cash consideration will be paid in lieu offractional Shares.

The Company is actively reviewing and assessinginvestment opportunities across multiple sectors to enhanceshareholder value.

On behalf of the Board of Directors of:

Orion Nutraceuticals Inc.

Guy Bourgeois, Director
Tel: ( 604) 687-2038

Information set forth in this press release may involveforward-looking statements. Forward-looking statements are statementsthat relate to future, not past, events. In this context,forward-looking statements often address a company’s expected futurebusiness and financial performance, and often contain words such as“anticipate”, “believe”, “plan”, “estimate”,“expect”, and “intend”, statements that an action or event“may”, “might”, “could”, “should”, or “will” betaken or occur, or other similar expressions. By their nature, forward-lookingstatements involve known and unknown risks, uncertainties and otherfactors which may cause our actual results, performance orachievements, or other future events, to be materially different fromany future results, performance or achievements expressed or impliedby such forward-looking statements. Such factorsinclude, among others, the following risks: the need for additionalfinancing; reliance on key personnel; and the potential for conflictsof interest among certain officers or directors with certain otherprojects. Forward-looking statements are made based on management’sbeliefs, estimates and opinions on the date that statements are madeand except as required by law, the Company undertakes no obligation toupdate forward-looking statements if these beliefs, estimates andopinions or other circumstances should change. Investors are cautionedagainst attributing undue certainty to forward-looking statements. Forfurther information on risk, investors are advised to see theCompany’s MD&A and other disclosure filings with the regulatorswhich are found at www.sedarplus.ca.

Copyright (c) 2025 TheNewswire - All rights reserved.